Question | Discussion | References | CME Credit

Case 4: Antiretrovirals and Oral Contraceptives

You answered:

B Raltegravir (Isentress) will markedly lower ethinyl estradiol and norethindrone levels.

This answer is incorrect. Raltegravir does not signifiantly alter ethinyl estradiol or norethinrone levels. Thus, raltegravir would not compromise the efficacy of the Ortho Novum 7/7/7 oral contraceptive.

Choose another answer:

A Efavirenz (Sustiva) will likely reduce the efficacy of the oral contraceptive pill.
C Darunavir (Prezista) boosted with ritonavir (Norvir) will significantly increase ethinyl estradiol and norethindrone levels.
D Lopinavir-ritonavir (Kaletra) will not impact ethinyl estradiol and norethindrone levels.

[Back to Case 4 Question | Go to Correct Answer]